Form 4: NV5 Director Disposes Shares in Acuren Merger
Insider Transaction Report
NV5 Global Director Francois Tardan disposed of 29,704 common shares as part of the company's merger with Acuren Corporation, receiving cash and Acuren stock.
Summary
- Director Francois Tardan of NV5 Global, Inc. reported the disposition of 29,704 shares of NV5 common stock.
- This transaction occurred on August 4, 2025, as a result of the merger between NV5 Global, Inc. and Acuren Corporation.
- Under the merger agreement dated May 14, 2025, each NV5 common share was converted into 1.1523 shares of Acuren common stock and $10.00 in cash.
- Any outstanding restricted stock units held by Mr. Tardan also vested in full immediately prior to the effective time of the mergers and converted into the merger consideration, less applicable tax withholdings.
- Following this transaction, Mr. Tardan beneficially owns 0 shares of NV5 Global, Inc.
Sentiment
Score: 7
Explanation: Neutral to slightly positive. The filing reports a standard insider transaction resulting from a merger, which is a pre-announced corporate action. For the reporting person, it signifies the conversion of their equity into the merger consideration, which includes both cash and stock, providing liquidity and continued participation. No negative surprises are indicated.
Positives
- The merger provides NV5 shareholders, including Director Tardan, with a combination of cash and shares in Acuren Corporation, offering immediate liquidity and continued equity participation in the combined entity.
- Restricted stock units held by the reporting person vested in full, converting into the merger consideration.
Negatives
- The reporting person no longer holds direct beneficial ownership in NV5 Global, Inc. common stock following the merger.
Future Outlook
No forward-looking statements or guidance from NV5 Global, Inc. are provided; this filing reports a historical transaction.
Industry Context
This filing indicates a significant consolidation event within the engineering, consulting, or testing services industry, where NV5 Global operates. The merger with Acuren Corporation suggests a strategic move to expand capabilities or market share, potentially creating a larger, more diversified entity.
Comparison to Industry Standards
- This Form 4 primarily reports an insider transaction resulting from a merger, rather than operational results. Therefore, direct comparison to industry standards for performance metrics is not applicable.
- The merger consideration (cash and stock) is a common structure for such transactions in the professional services sector, aiming to balance immediate value with future growth participation. Specific comparable companies or projects are not mentioned.
Stakeholder Impact
- Shareholders: NV5 shareholders received a pre-determined mix of cash and Acuren stock, converting their investment in NV5 into a new form.
- Employees: Not directly addressed, but mergers often lead to integration efforts that can impact employees.
- Customers/Suppliers: Not directly addressed, but the merger could lead to changes in service offerings or supply chain relationships.
Key Dates
| Date | Description |
|---|---|
| 05/14/2025 | Date of the Agreement and Plan of Merger between NV5 Global, Inc. and Acuren Corporation. |
| 08/04/2025 | Effective date of the merger, when NV5 common stock was converted into merger consideration. |
| 08/06/2025 | Date the Form 4 was signed by MaryJo OBrien, as attorney in fact for Francois Tardan. |
Recommendation
holdThis Form 4 reports a director's share disposition as a result of a completed merger. The investment decision regarding NV5 Global, Inc. would have been made prior to the merger's effective date. This filing provides no new material information to alter an investment thesis for the now-merged entity or Acuren Corporation.
Keywords
NV5 Global, Acuren Corporation, Merger, Form 4, Insider Trading, Stock Disposition, Corporate Action, Francois Tardan, NVEE
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.